Please login to the form below
Newron Pharma
This page shows the latest Newron Pharma news and features for those working in and with pharma, biotech and healthcare.
Newron back on track for Xadago approval in US
Newron Pharma will not have to conduct any additional clinical trials for its Parkinson's disease drug Xadago in the US, setting up a new FDA filing in the coming weeks. ... Now, Newron is planning to refile a marketing application with the FDA in
Latest news
-
Rare disease therapies head the ‘class of 2015’
maintaining the high output from pharma industry pipelines of the last few years. ... neprilysin inhibitor. Novartis. USA. safinamide. Xadago. Parkinson's disease. MAO-B inhibitor. Newron Pharma.
-
Chasing the cure for Parkinson's disease
Generic versions of this drug combination are also available, including Parcopa (Azur Pharma). ... Currently available therapies of this class include selegiline and rasagiline. Safinamide (Newron, Zambon and Meiji Seika Pharma) is a selective and
More from news
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest appointments
-
Newron Pharma appoints commercial affairs VP
Dennis Dionne brings expertise from J&J and Novartis. Milan, Italy-based Newron Pharmaceuticals has promoted Dennis Dionne to vice president of commercial affairs. ... Stefan Weber, chief executive officer of Newron, said: “We sincerely thanks Anders
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
- Top 10 benefits of virtual advisory boards: Save Time and Resources
- NIHR launches new framework to highlight health progress outcomes
- Johns Hopkins and National Cancer Unit develop new genetic risk-scoring method for major diseases
- UKHSA secures UK-based vaccine deal for future influenza pandemics
- Novo Nordisk and Valo Health agree deal worth up to $3.3bn to develop cardiovascular treatments
- Landscape review reveals £1.1bn of UK funding for rare diseases
No results were found
PMHub
Springer Nature
Operating in 50+ countries, we’re a leading research, educational, and professional publisher dedicated to advancing scientific discovery. Whether you’re looking...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
